Kodiak Sciences Inc.
KOD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001468748
No open-market purchases or sales by Kodiak Sciences Inc. insiders were filed in the last 90 days; 200 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Kodiak Sciences Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +10 vs. Q3 2024
- Shares held
- 42.1M
- +2.67M (+6.8%) vs. Q3 2024
- Total value
- $418.7M
- +$315.7M (+306.6%) vs. Q3 2024
- New holders
- 24
- 32 more added
- Sold out
- 14
- 29 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KOD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 200 | $2.36B |
| Q1 2026 | 188 | $2.21B |
| Q4 2025 | 158 | $1.61B |
| Q3 2025 | 121 | $727.8M |
| Q2 2025 | 101 | $155.7M |
| Q1 2025 | 107 | $120.3M |
| Q4 2024 | 108 | $418.7M |
| Q3 2024 | 98 | $103.0M |
| Q2 2024 | 106 | $94.3M |
| Q1 2024 | 114 | $228.0M |
| Q4 2023 | 96 | $124.7M |
| Q3 2023 | 101 | $76.5M |
| Q2 2023 | 128 | $293.6M |
| Q1 2023 | 127 | $254.8M |
| Q4 2022 | 136 | $298.2M |
| Q3 2022 | 143 | $324.6M |
| Q2 2022 | 131 | $313.1M |
| Q1 2022 | 142 | $330.5M |
| Q4 2021 | 153 | $3.82B |
| Q3 2021 | 153 | $4.37B |
| Q2 2021 | 149 | $4.18B |
| Q1 2021 | 167 | $5.02B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Kodiak Sciences Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ICONIQ Capital, LLC | 1,016,864 | $10.1M | 0.16% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,139,527 | $11.3M | 0.02% | +1,139,527 | New |
| TCG Crossover Management, LLC | 1,145,538 | $11.4M | 1.11% | +137,380+13.6% | Added |
| Price T Rowe Associates Inc | 1,268,509 | $12.6M | 0.00% | +1,257,063+10,982.6% | Added |
| Acadian Asset Management LLC | 1,532,313 | $15.2M | 0.04% | −421,885−21.6% | Reduced |
| Vanguard Group Inc | 1,682,209 | $16.7M | 0.00% | −2,920−0.2% | Reduced |
| BlackRock, Inc. | 3,727,531 | $37.1M | 0.00% | −210,401−5.3% | Reduced |
| Baker Bros. Advisors LP | 17,310,490 | $172.2M | 1.84% | 00.0% | Unchanged |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −740,505−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −493,548−100.0% | Sold out |
| Lynx1 Capital Management LP | 0 | $0 | 0.00% | −271,177−100.0% | Sold out |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −164,984−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −46,738−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −40,015−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −35,537−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −33,468−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −28,800−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −12,354−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −10,473−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −169−100.0% | Sold out |